Corrigendum to "Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome" [J Nutr Biochem (2014) 692-701] DOI: 10.1016/j.jnutbio.2014.02.011;Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome

Journal of Nutritional Biochemistry

Volumn 25, Issue 7, 2014, Pages 692-701

  Jacome Sosa, M Miriam ^a   Borthwick, Faye ^a   Mangat, Rabban ^a   Uwiera, Richard ^a   Reaney, Martin J ^b   Shen, Jianheng ^b   Quiroga, Ariel D ^a   Jacobs, René L ^a   Lehner, Richard ^a   Proctor, Spencer D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Energy expenditure; Fat redistribution; Insulin resistance; Saturated fat; Triglyceride secretion

Indexed keywords

STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; VACCENIC ACID; 11-OCTADECENOIC ACID; FAT INTAKE; FATTY ACID; INSULIN; OLEIC ACID;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DAIRY PRODUCT; DIET SUPPLEMENTATION; ENERGY CONSUMPTION; ENERGY EXPENDITURE; FAT MASS; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; LIPID DIET; LIPID HOMEOSTASIS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLIC RATE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; OBESITY; OXIDATION; RAT; TRANSCRIPTION REGULATION; ANIMAL; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; INSULIN RESISTANCE; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOPHYSIOLOGY; PHARMACOLOGY;

ANIMALIA; RATTUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; DAIRY PRODUCTS; DIETARY FATS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY ACIDS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OLEIC ACIDS; RATS;

EID: 84901841792     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.01.001     Document Type: Erratum

References (53)

1. Lock A.L., Bauman D.E. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 2004, 39:1197-1206.
2. Cruz-Hernandez C., Kramer J.K.G., Kennelly J.J., Glimm D.R., Sorensen B.M., Okine E.K., et al. Evaluating the conjugated linoleic acid and trans 18:1 isomers in milk fat of dairy cows fed increasing amounts of sunflower oil and a constant level of fish oil. J Dairy Sci 2007, 90:3786-3801.
3. Palmquist D.L., Lock A.L., Shingfield K.J., Bauman D.E. Biosynthesis of conjugated linoleic acid in ruminants and humans. Adv Food Nutr Res 2005, 50:179-217.
4. Banni S., Angioni E., Murru E., Carta G., Melis M.P., Bauman D., et al. Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland. Nutr Cancer 2001, 41:91-97.
5. Turpeinen A.M., Mutanen M., Aro A., Salminen I., Basu S., Palmquist D.L., et al. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 2002, 76:504-510.
6. Lock A.L., Horne C.A., Bauman D.E., Salter A.M. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. J Nutr 2005, 135:1934-1939.
7. Bauchart D., Roy A., Lorenz S., Chardigny J.M., Ferlay A., Gruffat D., et al. Butters varying in trans 18:1 and cis-9, trans-11 conjugated linoleic acid modify plasma lipoproteins in the hypercholesterolemic rabbit. Lipids 2007, 42:123-133.
8. Bassett C.M., Edel A.L., Patenaude A.F., McCullough R.S., Blackwood D.P., Chouinard P.Y., et al. Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J Nutr 2010, 140:18-24.
9. Wang Y., Lu J., Ruth M.R., Goruk S.D., Reaney M.J., Glimm D.R., et al. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. J Nutr 2008, 138:2117-2122.
10. Wang Y., Jacome-Sosa M.M., Ruth M.R., Goruk S.D., Reaney M.J., Glimm D.R., et al. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J Nutr 2009, 139:2049-2054.
11. Blewett H.J., Gerdung C.A., Ruth M.R., Proctor S.D., Field C.J. Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br J Nutr 2009, 102:526-536.
12. Ruth M.R., Wang Y., Yu H., Goruk S.D., Reaney M.J., Proctor S.D., et al. Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats. Nutrients 2010, 2:181-197.
13. Tyburczy C., Major C., Lock A.L., Destaillats F., Lawrence P., Brenna J.T., et al. Individual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. J Nutr 2009, 139:257-263.
14. Wang Y., Jacome-Sosa M.M., Ruth M.R., Shen J., Reaney M.J., Scott S.L., et al. The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome. Mol Nutr Food Res 2012, 56:1234-1246.
15. Musso G., Gambino R., De Michieli F., Cassader M., Rizzetto M., Durazzo M., et al. Dietary habits and their relations to insulin resitance and postprandial in nonalcoholic steatohepatitis. Hepatology 2003, 37:909-916.
16. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
17. Ohlsson L. Dairy products and plasma cholesterol levels. Food Nutr Res 2010, 54:5124.
18. Russell J.C., Proctor S.D. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol 2006, 15:318-330.
19. Vine D.F., Takechi R., Russell J.C., Proctor S.D. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR: LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis 2007, 190:282-290.
20. Swain M.L.B.B. Formation of traces of conjugated tetraenoic and trienoic constitutents in autoxidized linolenic and linoleic acids and vegetable oils during alkali-isomerization. JAOCS 1949, 26:272-277.
21. Carswell K.A., Lee M.J., Fried S.K. Culture of isolated human adipocytes and isolated adipose tissue. Methods Mol Biol 2012, 806:203-214.
22. Cousin S.P., Hügl S.R., Wrede C.E., Kajio H., Myers M.G., Rhodes C.J. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 2001, 142:229-240.
23. Russell J.C., Ahuja S.K., Manickavel V., Rajotte R.V., Amy R.M. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis 1987, 7:620-626.
24. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
25. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
26. Brunt E.M. Pathology of fatty liver disease. Modern Pathol 2007, 20:S40-S48.
27. Sahoo D., Trischuk T.C., Chan T., Drover V.A., Ho S., Chimini G., et al. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. J Lipid Res 2004, 45:1122-1131.
28. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
29. Deminice R., da Silva R.P., Lamarre S.G., Brown C., Furey G.N., McCarter S.A., et al. Creatine supplementation prevents the accumulation of fat in the livers of rats fed a high-fat diet. J Nutr 2011, 10:1799-1804.
30. Johnston T.P. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. J Cardiovasc Pharmacol 2004, 43:595-606.
31. Lehner R., Vance D.E. Cloning and expression of a cDNA encoding a hepatic microsomal lipase that mobilizes stored triacylglycerol. Biochem J 1999, 343:1-10.
32. Galgani J.E., Moro C., Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 2008, 295:E1009-E1017.
33. Kien C.L. Dietary interventions for metabolic syndrome: role of modifying dietary fats. Curr Diab Rep 2009, 9:43-50.
34. Sacks F.M., Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 2002, 113:13S-24S.
35. Galgani J.E., Heilbronn L.K., Azuma K., Kelley D.E., Albu J.B., Pi-Sunyer X., et al. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008, 57:841-845.
36. Langin D., Holm C., Lafontan M. Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc 1996, 55(1B):93-109.
37. Mohankumar S.K., Hanke D., Siemens L., Cattini A., Enns J., Shen J., et al. Dietary supplementation of trans-11-vaccenic acid reduces adipocyte size but neither aggravates nor attenuates obesity-mediated metabolic abnormalities in fa/fa Zucker rats. Br J Nutr 2013, 109:1628-1636.
38. Johnson J.A., Trasino S.E., Ferrante A.W., Vasselli J.R. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats. Obesity 2007, 15:2653-2663.
39. Jacome-Sosa M.M., Lu J., Wang Y., Ruth M.R., Wright D.C., Reaney M.J., et al. Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat. Nutr Metab (Lond) 2010, 7:60-70.
40. McQuaid S.E., Hodson L., Neville M.J., Dennis A.L., Cheeseman J., Humphreys S.M., et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?. Diabetes 2011, 60:47-55.
41. Ferré P., Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010, 12:83-92.
42. Jay M.A., Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev 2007, 3:33-39.
43. Duval C., Müller M., Kersten S. PPARalpha and dyslipidemia. Biochim Biophys Acta 2007, 1771:961-971.
44. Wu X., Chen K., Williams K.J. The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia. Curr Opin Lipidol 2012, 23:334-344.
45. Schrauwen P., Hoppeler H., Billeter R., Bakker A.H., Pendergast D.R. Fiber type dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by high-fat diet. Int J Obes Relat Metab Disord 2001, 25:449-456.
46. Deng S., Yang Y., Han Y., Li X., Zhang Z., Wang Y. UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions. PLoS One 2012, 7:e30714.
47. Collins P., Jones C., Choudhury S., Damelin L., Hodgson H. Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis. Liver Int 2005, 25:880-887.
48. Echtay K.S., Murphy M.P., Smith R.A., Talbot D.A., Brand M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 2002, 277:47129-47135.
49. Lee F.Y., Li Y., Zhu H., Yang S., Lin H.Z., Trush M., et al. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology 1999, 29:677-687.
50. Horimoto M., Resnick M.B., Konkin T.A., Routhier J., Wands J.R., Baffy G. Expression of uncoupling protein-2 in human colon cancer. Clin Cancer Res 2004, 10:6203-6207.
51. Zoltowska M., Ziv E., Delvin E., Sinnett D., Kalman R., Garofalo C., et al. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 2003, 52:2539-2545.
52. Haidari M., Leung N., Mahbub F., Uffelman K.D., Kohen-Avramoglu R., Lewis G.F., et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. J Biol Chem 2002, 277:31646-31655.
53. Federico L.M., Naples M., Taylor D., Adeli K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia. Diabetes 2006, 55:1316-1326.